Health Care Select Sector SPDR Fund vs Exxon Mobil Corporation — how do they compare? Health Care Select Sector SPDR Fund trades at $171.01 (market cap $43.48B), while Exxon Mobil Corporation trades at $168.93 (market cap $692.86B). The key difference: Exxon Mobil Corporation is far larger — about 15.9× Health Care Select Sector SPDR Fund's market cap, and Exxon Mobil Corporation pays a 2.45% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.
| XLV | XOM | |
|---|---|---|
Market Cap | $43.48B | $692.86B |
Volume | 11,121,431 | 13,225,996 |
52-Week High | $175.68 | $171.52 |
52-Week Low | $141.95 | $110.64 |
Typical Hold Time | 100 Days | — |
Sector | — | Energy |
Enterprise Value | — | $724.64B |
Dividend Yield | — | 2.45% |
Signals from Pluang's Aura AI — not financial advice
XLV trades at $169.58 with a slight 0.46% daily gain amid bearish technical signals. The ETF faces selling pressure with moving averages indicating downward momentum while oscillators remain neutral. Recent news highlights XLV's competitive expense ratio of 0.08% and defensive healthcare sector positioning. Options activity shows increased put volume, suggesting some investor caution despite the fund's diversification across 61 healthcare stocks.
The healthcare ETF presents a cost-effective defensive play with potential upside if political volatility subsides post-elections. Key risks include sector-specific regulatory pressures and biotech trial failures impacting holdings. Current technical weakness near support at $166 requires monitoring for potential breakdown, though the fund's low fees and broad diversification provide stability during market uncertainty.
Exxon Mobil (XOM) trades at $164.06, down 0.26% on the day, with a bullish technical signal and strong support at $163. The company reported mixed Q2 2026 earnings, missing EPS estimates, but maintains solid profitability with a 9.07% net margin. Recent news highlights potential expansion into Venezuela's oil fields and ongoing growth in Guyana and Permian Basin assets. Cash flow from operations remains robust at $52.0 billion in 2025, though net cash flow was negative due to high capital expenditures.
XOM offers a stable dividend and growth potential from strategic investments, but faces risks from volatile oil prices and geopolitical exposure. Analyst consensus is a 'Hold' with a $169.45 price target, indicating modest upside. Revenue declines from 2022-2025 pose a concern, but projected 2026 growth to $361.1 billion may reverse the trend. The stock's valuation ratios, including a P/E of 21.69, are reasonable for the energy sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.
Read more on XOM →